Home LiteratureArticle Details
PMID: 1682736 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Rapid diagnosis of hantavirus disease with an IgG-avidity assay.

Lancet (London, England) ·Vol. 338 ·No. 8779 ·1991-11-30 ·Pages 1353-6

Hedman K, Vaheri A, Brummer-Korvenkontio M

Abstract

Nephropathia epidemica (NE), due to Puumala virus, is endemic in eastern Europe and Scandinavia. Serodiagnosis of NE relies on conventional indirect immunofluorescence to detect IgG against Puumala virus. However, in conventional serology, most patients with acute NE have raised but stable non-diagnostic antibody titres. For better serodiagnosis of NE, we have developed a test that measures the avidity (functional affinity) of IgG antibodies against Puumala virus. This new assay was highly specific and sensitive; a diagnosis of NE could be confirmed or excluded rapidly from an early single serum sample. With this test we have now verified the diagnosis of NE in more than 1300 Finnish patients during 22 months in 1989-91. Our findings point to an incidence of confirmed hantavirus disease much higher than previously shown.

MeSH Terms
Antibodies, Viral/blood Antibody Affinity Hantavirus/immunology Hemorrhagic Fever with Renal Syndrome/diagnosis,immunology Humans Immunoglobulin G/blood Sensitivity and Specificity
Chemicals
Antibodies, Viral Immunoglobulin G
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Hedman K
Department of Virology, University of Helsinki, Finland.
Vaheri A
Brummer-Korvenkontio M
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
1991-11-30
Pages
1353-6
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com